1. Allayee, H.; Laffitte, B. A.; Lusis, A. J., Biochemistry. An absorbing study of cholesterol. Science 2000, 290, (5497), 1709-11.
2. Vance, D. E.; Van den Bosch, H., Cholesterol in the year 2000. Biochim Biophys Acta 2000, 1529, (1-3), 1-8.
3. Harvey, P. C. C. a. R. A., Lippincotts Illustrated Review Biochemistry. 2/e ed.; Lippincott Williams & Wilkins: 2001; p 205-227 ; 173-185.
4. Simons, K.; Toomre, D., Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000, 1, (1), 31-9.
5. Simons, K.; Ehehalt, R., Cholesterol, lipid rafts, and disease. J Clin Invest 2002, 110, (5), 597-603.
6. Chugh, A.; Ray, A.; Gupta, J. B., Squalene epoxidase as
hypocholesterolemic drug target revisited. Prog Lipid Res 2003, 42, (1), 37-50.
7. Dougherty, D. A., Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 1996, 271, (5246), 163-8.
8. Grundy, S. M., HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 1988, 319, (1), 24-33.
9. Abe, I., Enzymatic Cyclization of Squalene and Oxidosqualene to Sterols and Triterpenes. Chem. Rev. 1993, pp 2189-2206.
10. Shi, Z.; Buntel, C. J.; Griffin, J. H., Isolation and characterization of the gene encoding 2,3-oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 1994, 91, (15), 7370-4.
11. Baker, C. H.; Matsuda, S. P.; Liu, D. R.; Corey, E. J., Molecular cloning of the human gene encoding lanosterol synthase from a liver cDNA library. Biochem Biophys Res Commun 1995, 213, (1), 154-60.
12. Poralla, K.; Hewelt, A.; Prestwich, G. D.; Abe, I.; Reipen, I.; Sprenger, G.,
15. Wu, T. K.; Griffin, J. H., Conversion of a plant
oxidosqualene-cycloartenol synthase to an oxidosqualene-lanosterol cyclase by random mutagenesis. Biochemistry 2002, 41, (26), 8238-44.
16. Bloch, K., The biological synthesis of cholesterol. Science 1965, 150, 19-28.
17. Huff, M. W.; Telford, D. E., Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear. Trends Pharmacol Sci 2005, 26, (7), 335-40.
18. Wendt, K. U.; Poralla, K.; Schulz, G. E., Structure and function of a squalene cyclase. Science 1997, 277, (5333), 1811-5.
19. Hoshino, T., Squalene-hopene cyclase: catalytic mechanism and substrate recognition. Chem. Commun. (Camb.) 2002, 4, 291-310.
20.Thoma, R.; Schulz-Gasch, T.; D'Arcy, B.; Benz, J.; Aebi, J.; Dehmlow, H.;
Hennig, M.; Stihle, M.; Ruf, A., Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase. Nature 2004, 432, (7013), 118-22.
21. Nelson, J. A., Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide. J. Biol. Chem. 1981, 256, 1067-1068.
22. Boutaud, O.; Dolis, D.; Schuber, F., Preferential cyclization of 2,3(S):22(S),23-dioxidosqualene by mammalian
2,3-oxidosqualene-lanosterol cyclase. Biochem Biophys Res Commun 1992, 188, (2), 898-904.
23. Rowe, A. H.; Argmann, C. A.; Edwards, J. Y.; Sawyez, C. G.; Morand, O.
H.; Hegele, R. A.; Huff, M. W., Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of
2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circ Res 2003, 93, (8), 717-25.
24. Ory, D. S., Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circ. Res. 2004, 95, 660-670.
25. Dollis, D.; Schuber, F., Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2. Biochem Pharmacol 1994, 48, (1), 49-57.
26. Mark, M.; Muller, P.; Maier, R.; Eisele, B., Effects of a novel
2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. J Lipid Res 1996, 37, (1), 148-58.
27. Morand, O. H.; Aebi, J. D.; Dehmlow, H.; Ji, Y. H.; Gains, N.; Lengsfeld,
H.; Himber, J., Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin. J Lipid Res 1997, 38, (2), 373-90.
28. Peffley, D. M.; Gayen, A. K.; Morand, O. H., Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor
[4'-(6-allyl-ethyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-m e thanone (Ro 48-8071): comparison to simvastatin. Biochem Pharmacol 1998, 56, (4), 439-49.
29. Gardner RG, S. H., Matsuda SPT, Hampton RY., An oxysterol-derived positive signal for 3-hydroxy-3-methylglutaryl-CoA reductase
degradation in yeast. J Biol Chem. 2001, 276, 8681-8694.
30. Janowski BA, S. B., Russell DW., The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. J Biol Chem 2001, 276, 45408-45416.
31. Telford, D. E.; Lipson, S. M.; Barrett, P. H.; Sutherland, B. G.; Edwards, J.
Y.; Aebi, J. D.; Dehmlow, H.; Morand, O. H.; Huff, M. W., A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content. Arterioscler Thromb Vasc Biol 2005, 25, (12), 2608-14.
32. Corey, E. J. M., S. P. T. , Purification of the 2,3-Oxidosqualene-lanosterol Cyclase from Saccharomyces cerevisiae. J. Am. Chem. Soc. 1991, 113, 8172-8174.
33. Abe, I.; Zheng, Y. F.; Prestwich, G. D., Photoaffinity labeling of
37. Wu, T. K.; Huang, C. Y.; Ko, C. Y.; Chang, C. H.; Chen, Y. J.; Liao, H. K., Purification, tandem mass characterization, and inhibition studies of
oxidosqualene-lanosterol cyclase enzyme from bovine liver. Arch Biochem Biophys 2004, 421, (1), 42-53.
38. Cattel, L.; Ceruti, M., Inhibitors of 2,3-oxidosqualene cyclase as tools for studying the mechanism and function of the enzyme. Crit Rev Biochem Mol Biol 1998, 33, (5), 353-73.
39. Wendt, K. U.; Lenhart, A.; Schulz, G. E., The structure of the membrane protein squalene-hopene cyclase at 2.0 A resolution. J Mol Biol 1999, 286, (1), 175-87.
40. Corey, E. J.; Cheng, H.; Baker, C. H.; Matsuda, S. P. T.; Li, D.; Song, X., Methodology for the Preparation of Pure Recombinant S.cereVisiae Lanosterol
Synthase Using a Baculovirus ExpressionSystem. Evidence That Oxirane Cleavage and A-RingFormation Are Concerted in the Biosynthesis of Lanosterolfrom 2,3-Oxidosqualene. J. Am. Chem. Soc. 1997, 119, 1277-1288
41. Dang, T.; Abe, I.; Zheng, Y. F.; Prestwich, G. D., The binding site for an inhibitor of squalene:hopene cyclase determined using photoaffinity labeling and molecular modeling. Chem Biol 1999, 6, (6), 333-41.
42. Lenhart, A.; Weihofen, W. A.; Pleschke, A. E.; Schulz, G. E., Crystal structure of a squalene cyclase in complex with the potential
anticholesteremic drug Ro48-8071. Chem Biol 2002, 9, (5), 639-45.
43. Shuster, J. R., Regulated transcriptional systems for the production of proteins in yeast: regulation by carbon source. Yeast Genetic Engineering 1989.
44. Hinnen A, M. B., Heim J., Heterologous gene expression in yeast. Yeast Genetic Engineering 1989, 193-214.
45. Smith RA, D. M., Moir DT, Heterologous protein secretion from yeast.
Science 1985, 229, 1219-1224.
46. Zsebo KM, L. H., Fieschko JC, Goldstein L, Davis J, Duker K, Suggs SV, Lai PH, Bitter GA, Protein secretion from Saccharomyces cerevisiae directed by the prepro-a-factor leader region. J Biol Chem 1986, 261, 5858-5865.
47. de Nobel JG, B. J., Passage of molecules through yeast cell wall: a brief essay-review. Yeast 1991, 7, 313-323.
48. Cregg JM, T. J., Stillman C, Siegel R, Akong M, Craig WS, Buckholz RG, Madden KR, Kellaris PA, Davis GR, Smiley BL, Cruze J, Torregrossa R, Velicelebi G, Thill GP, High-level expression and efficient assembly of
hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris.
BioTechology 1987, 5, 479-485.
49. Janowicz ZA, M. K., Merckelbach A, Jacobs E, Harford N, Comberbach M, Hollenberg CP, Simultanneous expression of the S and L surface antigen of hepatitis B, and formation of mixed particles in the
methylotropic yeast, Hansenula polymorpha. Yeast 1991, 7, 431-433.
50. Broker M, B. O., New expression vector for the fission yeast Schizosaccharomyces pombe. FEBS Lett 1989, 248, 105-110.
51. Franke AE, K. F., Eisenhard ME, Geoghegan KF, Danley DE, de Zeeuw JR, o’Donnell MM, Gollaher MG, Davidow LS, Expression and secretion of bovine prochymosin in Yarrowia lipotica. Devel Ind Microbiol 1988, 29, 43-57.
52. van de Berg JA, v. d. L. K., van Ooyen JJ, Renniers TCH, Rietveld D, Schaap A, Brake J, Bishop RJ, Schultz K, Moyer D, Richman M, Shuster JR, Kluyveromyces as a host for heterologous gene expression:
expression and secretion of prochymosin. Bio Technology 1990, 8, 135-139.
53. Piontek M, H. C., Strasser AWM, Schwanniomyces occidentalis: a promising system for the expression of foreign gene. Yeast 1990, 6, 422-430.
54. Ogata K, N. H., Ohsugi M, A yeast capable of utilizing methanol. Agric BiolChem 1969, 33, 1519-1520.
55. Cregg JM, M. K., Barringer KJ, Thill GP, Stillman CA, Functional characterization of the two alcohol oxidase gene from the yeast Pichia pastoris. Mol Cell Biol 1989, 9, 1316-1323.
56. Egli T, v. D. J., Veenhuis M, Harder W, Fiechter A, Methanol metabolism in yeasts: regulation of the synthesis of catabolic enzymes. Arch
Microbiol 1980, 124, 115-121.
pastoris. Gene 1998, 216, 93-102.
61. Liu H, T. X., Russell KA, Veenhuis M, Cregg JM., PER3, a gene required for peroxisome biogenesis in Pichia pastoris, encodes a peroxisomal membrane protein involved in protein import. J Biol Chem 1995, 270, 10940-10951.
62. Sears IB, O. C. J., Rossanese OW, Glick BS, A versatile set of vectors for constitutive and regulated gene expression in Pichia pastoris. Yeast 1998, 44, 738-790.
63. Cregg JM, M. K., Use of site-specific recombination to regenerate selectable markers. Mol Gen Genet 1993, 219, 320-323.
64. Cregg JM, M. K., Use of site-specific recombination to regenerate selectable markers. Mol Gen Genet 1989, 219, 320-323.
65. Scorer CA, C. J., McCombie WR, Romanos MA, Sreekrishna K., Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Biotechnology 1994, 12, 181-184.
66. Brocca S, S.-D. C., Lotti M, Alberghina L, Schmid DR., Design, total synthesis, and functional over expression of the Candida rugosa lip1 gene coding for a major industrial lipase. Protein Sci 1998, 7, 1415-1422.
67. Kurjan J, H. I., Structure of the yeast pheromone gene (MF alpha) : a putative alpha-factor precursor contains four tandem copies of mature alpha- factor. Cell 1982, 30, 933-943.
68. Martínez-Ruiz A, M. d. P. A., Lacadena J, Mancheño JM, Oñaderra M, López-Otin C, Gavianes AJG, Secretion of recombinant pro- and mature fungal a-sarcin ribotoxin by the methylotrophic yeast Pichia pastoris: the Lys-Arg motif is required for maturation. Protein Expr Purif 1998, 12, 315-322.
69. Kjeldsen T, P. A., Hach M, Secretory expression and characterization of insulin in Pichia pastoris. Biotechnol Appl Biochem 1999, 29, 79-86.
70. Romanos M, Advances in the use of Pichia pastoris for high- level gene expression. Biotechnology 1995, 6, 527-533.
71. Bauer, D. C., HMG CoA reductase inhibitors and the skeleton: a comprehensive review. Osteoporos Int 2003, 14, (4), 273-82.
72. Goldman, J. A.; Fishman, A. B.; Lee, J. E.; Johnson, R. J., The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Arthritis Rheum 1989, 32, (3), 358-9.
73. Wendt, K. U.; Schulz, G. E.; Corey, E. J.; Liu, D. R., Enzyme
Mechanisms for Polycyclic Triterpene Formation. Angew Chem Int Ed
Engl 2000, 39, (16), 2812-2833.
74. DiDomenico, B., Novel antifungal drugs. Curr Opin Microbiol 1999, 2, (5), 509-15.
75. Lenhart, A.; Reinert, D. J.; Aebi, J. D.; Dehmlow, H.; Morand, O. H.;
Schulz, G. E., Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase. J Med Chem 2003, 46, (11), 2083-92.
76. abe, i. e. a., Purification of 2,3-oxidosqualene : bata-amyrin cyclase from pea seedlings. chem. Pharm. Bull. 1989, 37, 536~538.
77. Armin Ruf, F. M. u., Brigitte D’Arcy, Martine Stihle, Eric Kusznir,
Corinne Handschin, Olivier H. Morand, and Ralf Thoma, The monotopic membrane protein human oxidosqualene cyclase is active as monomer.
Biochem Biophys Res Commun 2004, 315, (2), 247-54.
78. E. J. Corey, H. C., C. Hunter Baker, Seiichi P. T. Matsuda, Ding Li, and Xuelei Song, Methodology for the Preparation of Pure Recombinant S.
cereVisiae Lanosterol Synthase Using a Baculovirus Expression System.
Evidence That Oxirane Cleavage and A-Ring Formation Are Concerted in the Biosynthesis of Lanosterol from 2,3-Oxidosqualene. J. Am. Chem.
Soc. 1997, 119, 1277-1288.
79. 柯震宇, 牛肝中氧化鯊烯-羊毛硬脂醇環化酵素之生化特性與抑制作 用的探討. 碩士論文,國立交通大學生物科技研究所 2002.
80. Akio Ojida, H. T., Noriyuki Kasagi and Itaru Hamachi, Suzuki coupling for protein modification. Tetrahedron Letters 2005, 46, 3301-3305.